BIO-key International, Inc. (BKYI)

Industrials · NCM

$2.28-18.57% today

Price as at 1 Oct 2026, 17:49 UTC. Quotes are delayed.

Fundamentals

Market cap$4.76M
Revenue growth (YoY)+33.5%
Profit margin-102.3%
Return on equity-106.7%
52-week range$1.63 to $19.70

Valuation and ratings

Fair value estimate$4.51
Upside to fair value+97.8%
Analyst target (mean)$20.00
Analyst range$20.00 to $20.00
Analysts with price targets1
Consensus viewbuy
Moat score45/100
Overall rating46/100, moderate quality

Fair value: $4.51 (+97.8%), see how we got there

BIO-key International, Inc. trades at $2.28, which is 98% below the $4.51 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.

Our moat model scores it 45 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

BKYI dividend history

No individual payments are on record for this listing, so the current facts above are all we can honestly show.

BKYI earnings and analyst estimates

EPS estimate, next year$0.22
Expected EPS growth+113.6%
Expected revenue growth+33.3%

Recommendation mix, 1 published rating

1 buy0 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About BIO-key International, Inc.

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS cloud-based identity platforms, which allows authentication through an IAM platform; and BIO-key VST and WEB-key; civil and large-scale ID infrastructure. The company also provides fingerprint readers for commercial companies under the SidePass, SideSwipe, and EcoID II brands; and identity and access management, user multi-factor authentication, single sign on, privilege entitlement, and access control. It serves commercial, government, and education customers. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.

Industry: Security & Protection ServicesEmployees: 41HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

BKYI passes 3 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

BKYI peers

The largest companies in the same industry (Security & Protection Services), then in the same sector.

Every industrials company we cover is on the Industrials hub.

Common questions

Is BIO-key International, Inc. (BKYI) undervalued?

Against our fair value estimate of $4.51, BKYI at $2.28 is 98% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.

Where does SteadyShares get its BKYI data?

Fundamentals for BKYI come from company filings and exchange data, as listed on NCM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 17:49 UTC and is delayed. Our data quality score for this company is 83/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for BKYI, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.